Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 10 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026 and Aug 2026.
- Largest single sale: $1.8M (19,048 shares) of Corcept Therapeutics Inc on Jul 7, 2026. Filing
- Last sale before this period: Oct 7, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Corcept Therapeutics Inc (CORT) | Chief Development Officer | Sep 3, 2021 | Sep 3, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 1, 2026, Corcept Therapeutics Inc: 328 shares awarded. 1 filing: 1
- Aug 10, 2026, Corcept Therapeutics Inc: sold 16,300 shares for $1.8M, under a disclosed plan; 16,300 shares acquired by exercising options. 1 filing: 1
- Aug 4, 2026, Corcept Therapeutics Inc: sold 3,700 shares for $419K, under a disclosed plan; 3,700 shares acquired by exercising options. 1 filing: 1
- Jul 7, 2026, Corcept Therapeutics Inc: sold 20,000 shares for $1.9M, under a disclosed plan; 20,000 shares acquired by exercising options. 1 filing: 1
- Jun 2, 2026, Corcept Therapeutics Inc: sold 20,000 shares for $1.4M, under a disclosed plan; 20,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.